Interleukin-1, Neutrophil Elastase, and Lipopolysaccharide: Key Pro-Inflammatory Stimuli Regulating Inflammation in Cystic Fibrosis

被引:4
作者
Carroll, Tomas P. [1 ]
Greene, Catherine M. [1 ]
Taggart, Clifford C. [1 ]
McElvaney, Noel G. [1 ]
O'Neill, Shane J. [1 ]
机构
[1] Beaumont Hosp, Royal Coll Surg Ireland, Educ & Res Ctr, Resp Res Div, Dublin 9, Ireland
关键词
Interleukin-1; Neutrophil elastase; Lipopolysaccharide; Cystic Fibrosis; Inflammation;
D O I
10.2174/1573398052953640
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Cystic fibrosis (CF) is a common fatal genetic disease among Caucasians of European descent that is characterized by neutrophil-dominated airway inflammation due to intrinsic cellular abnormalities in the affected epithelial cells. A number of proinflammatory stimuli are responsible for aggravating inflammatory responses in CF bronchial epithelium. Two important host-derived factors with potent proinflammatory effects in CF are interleukin-1 (IL-1) and neutrophil elastase (NE). Microbial-derived factors also have importance in the CF lung, as a significant factor by which pulmonary inflammation is mediated in CF is by Pseudomonas aeruginosa infection. Pseudomonas antigens, including lipopolysaccharide (LPS), can exacerbate pulmonary inflammation in CF by exaggerating proinflammatory gene expression via Toll-like receptor (TLR) activation. TLRs belong to a family of proteins that can recognize and discriminate a diverse array of microbial antigens. Following their activation TLRs transduce intracellular signals that regulate proinflammatory gene expression. Intriguingly IL-1, NE and LPS all utilize the same intracellular signaling pathways to induce their effects. This review will summarise what is known regarding the roles of these important proinflammatory stimuli and their effects on CF epithelium and describe current and novel therapeutic strategies for the treatment of CF lung disease.
引用
收藏
页码:43 / 67
页数:25
相关论文
共 289 条
  • [1] Toll-like receptors in the induction of the innate immune response
    Aderem, A
    Ulevitch, RJ
    [J]. NATURE, 2000, 406 (6797) : 782 - 787
  • [2] MARKED GOBLET CELL HYPERPLASIA WITH MUCUS ACCUMULATION IN THE AIRWAYS OF PATIENTS WHO DIED OF SEVERE ACUTE ASTHMA ATTACK
    AIKAWA, T
    SHIMURA, S
    SASAKI, H
    EBINA, M
    TAKISHIMA, T
    [J]. CHEST, 1992, 101 (04) : 916 - 921
  • [3] IFN-α and IFN-β: A link between immune memory and chronic inflammation
    Akbar, AN
    Lord, JM
    Salmon, M
    [J]. IMMUNOLOGY TODAY, 2000, 21 (07): : 337 - +
  • [4] Toll-like receptor signaling
    Akira, S
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (40) : 38105 - 38108
  • [5] Toll-like receptors: critical proteins linking innate and acquired immunity
    Akira, S
    Takeda, K
    Kaisho, T
    [J]. NATURE IMMUNOLOGY, 2001, 2 (08) : 675 - 680
  • [6] A SOLUBLE RECEPTOR FOR INTERLEUKIN-1-BETA ENCODED BY VACCINIA VIRUS - A NOVEL MECHANISM OF VIRUS MODULATION OF THE HOST RESPONSE TO INFECTION
    ALCAMI, A
    SMITH, GL
    [J]. CELL, 1992, 71 (01) : 153 - 167
  • [7] Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
    Alexopoulou, L
    Holt, AC
    Medzhitov, R
    Flavell, RA
    [J]. NATURE, 2001, 413 (6857) : 732 - 738
  • [8] Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis:: a double-blind placebo-controlled trial
    Alton, EWFW
    Stern, M
    Farley, R
    Jaffe, A
    Chadwick, SL
    Phillips, J
    Davies, J
    Smith, SN
    Browning, J
    Davies, MG
    Hodson, ME
    Durham, SR
    Li, D
    Jeffery, PK
    Scallan, M
    Balfour, R
    Eastman, SJ
    Cheng, SH
    Smith, AE
    Meeker, D
    Geddes, DM
    [J]. LANCET, 1999, 353 (9157) : 947 - 954
  • [9] Activation of ΔF508 CFTR in a cystic fibrosis respiratory epithelial cell line by 4-phenylbutyrate, genistein and CPX
    Andersson, C
    Roomans, GM
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2000, 15 (05) : 937 - 941
  • [10] Mutations in the neutrophil elastase gene in cyclic and congenital neutropenia
    Aprikyan, AAG
    Dale, DC
    [J]. CURRENT OPINION IN IMMUNOLOGY, 2001, 13 (05) : 535 - 538